Iacocca foundation backs autoimmune program at Kineta

Like every small biotech, Seattle-based Kineta is always on the lookout for new investors and negotiating the best deal terms it can get. Along those lines, the developer gained a prize addition to its list of backers with word that Lee Iacocca's family foundation is putting some of its money behind one of Kineta's autoimmune disease programs (ShK-186). Iacoccas's first wife died of diabetes. And like a lot of foundations which are getting involved in finding new drugs, it's more interested in a better therapy than making money on its investments. Story